|
Last
Update:
July 14, 2007
Journal Papers, Abstracts, and
Commentaries
| |
Endocrinologic and immunologic factors associated with recovery
of growth in children
ith human immunodeficiency virus type 1infection treated with protease inhibitors.
Van Rossum AM, Gaakeer MI, Verweel S, et al.
Pediatr Infect Dis J 2003 Jan;22(1):70-6
Abstract
| |
Treatment With Highly Active Antiretroviral Therapy in
Human
Immunodeficiency
Virus Type 1
-Infected Children Is Associated With a Sustained Effect on Growth.
Verweel G, van Rossum AM, Hartwig NG, et al.
Pediatrics
2002 Feb;109(2):E25-E25
Abstract |
| |
Growth in human immunodeficiency virus-infected children
receiving ritonavir-ontaining
antiretroviral therapy.
Nachman SA, Lindsey JC, Pelton S, et al
Arch Pediatr Adolesc Med 2002
May;156(5):497-503
Abstract |
| |
Maternal and infant factors associated with failure to thrive in
children with vertically
transmitted human immunodeficiency
virus-1 infection: the prospective, P2C2 human
immunodeficiency
virus multicenter study.
Miller TL, Easley KA, Zhang W, et al.
Pediatrics 2001 Dec;108(6):1287-96
Abstract |
| |
Impact of protease inhibitor-containing combination antiretroviral
therapies on height and
weight growth in HIV-infected children.
Buchacz K, Cervia JS, Lindsey JC, et al
Pediatrics 2001 Oct;108(4):E72
Abstract |
| |
Developmental milestones of vertically HIV infected and
seroreverters children: follow up
of 83 children.
Bruck I, Tahan TT, Cruz CR, Martins LT, et al.
Arq Neuropsiquiatr 2001
Sep;59(3-B):691-5
Abstract |
|
|
|
HIV
Infection/Disease
Pediatric Main Page